Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 71 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Plain-language summary

Tracking over 10,000 people for 27 years, this landmark study found that being obese in midlife (in your 40s) nearly doubled the risk of developing dementia decades later, and being overweight also raised the risk, independent of whether someone later developed diabetes or heart disease.

What this study adds

Evidence grade: High

This is a follow-up (cohort) study of 10,276 participants. Being obese in midlife was linked to 74% higher dementia risk decades later, and being overweight to 35% higher risk, independent of later diabetes or heart disease. This identifies midlife obesity as a modifiable risk factor, but it does not show that losing weight prevents dementia.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., Jr., & Yaffe, K. (2005). Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. https://doi.org/10.1136/bmj.38446.466238.e0

Vancouver

Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005. doi:10.1136/bmj.38446.466238.e0. PMID: 15863436.

BibTeX

@article{whitmer2005-fcf9e1f2,
  author  = {Whitmer, R. A. and Gunderson, E. P. and Barrett-Connor, E. and Quesenberry, Jr., C. P. and Yaffe, K.},
  title   = {{Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study}},
  journal = {BMJ},
  year    = {2005},
  doi     = {10.1136/bmj.38446.466238.e0},
  pmid    = {15863436},
  url     = {https://doi.org/10.1136/bmj.38446.466238.e0}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

Being obese in midlife was linked to 74% higher dementia risk decades later, and being overweight to 35% higher risk, independent of later diabetes or heart disease. This identifies midlife obesity as a modifiable risk factor, but it does not show that losing weight prevents dementia.

Study details

Limitations

Body weight/adiposity was measured only once in midlife, with no data on later-life weight changes; the study population came from an insured healthcare system (Kaiser Permanente) that may not generalize to uninsured or lower-access populations; observational, so residual confounding by diet or lifestyle is possible.

How this study scored 71/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read left out, no data. 44 of the 62 points it could be judged on, which is 71 of 100. Total 71 of 100.44 of the 62 points we could judge = 71 of 100

Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 44 of the 62 points we could judge it on, which is 71 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (BMJ)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A cohort study following people over time
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2005 — older than 20 years, still counted
Sample size 4 / 4 10,276 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 15863436)
Free to read — / 2 Access not recorded — left out of this score
Points 44 / 62 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 44 of the 62 points we could judge it on is 71 out of 100.
Total 71 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

47 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Prevention and risk from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →